Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Dysregulation Disorder”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Testing effectiveness (Phase 2)Looking for participantsNCT04339777
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

Who this might be right for
Lymphoproliferative DisordersAutoimmune LymphoproliferativeImmune System Diseases+2 more
National Cancer Institute (NCI) 66
Not applicableLooking for participantsNCT03215836
What this trial is testing

Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics

Who this might be right for
AsthmaObesityMetabolic Syndrome
University of Colorado, Denver 50
Not applicableLooking for participantsNCT07637474
What this trial is testing

Immune Metabolism Dysregulation and Efficacy to Anti-PD-1 PD-L1 Agents in Non Small Cell Lung Cancer Patients

Who this might be right for
Nsclc
Regina Elena Cancer Institute 150
Not applicableLooking for participantsNCT06915831
What this trial is testing

Type 1 Diabetes and Obstructive Sleep Apnea

Who this might be right for
Sleep Apnea, ObstructiveType 1 Diabetes (T1D)
University of Chicago 40
Not applicableUnknownNCT06223100
What this trial is testing

Efficacy and Safety of the Combination Therapy Based on Eravacycline in Immunocompromised Hosts With MDROS Infection

Who this might be right for
Immune Dysregulation Disorder
Sichuan Provincial People's Hospital 100
Not applicableStudy completedNCT02475486
What this trial is testing

Role of the ANS Dysregulation in the Persistence of Fatigue in Rheumatoid Arthritis Patients Treated With Anti-TNF

Who this might be right for
Rheumatoid Arthritis
Centre Hospitalier Universitaire de Saint Etienne 50
Testing effectiveness (Phase 2)Ended earlyNCT01596699
What this trial is testing

Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Myeloid MalignancyBone Marrow Failure SyndromeTransfusion-dependent Red Blood Cell (RBC) Defect+3 more
University of California, San Francisco 16
Testing effectiveness (Phase 2)Study completedNCT05965726
What this trial is testing

RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms

Who this might be right for
Long COVID-19Long COVID
Kanecia Obie Zimmerman 964
Not applicableStudy completedNCT03119883
What this trial is testing

Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificancePlasma Cell Myeloma
Mayo Clinic 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT02990819
What this trial is testing

Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary Immunodeficiencies

Who this might be right for
ImmunodeficienciesImmune Dysregulation Syndromes
Children's Hospital of Philadelphia 60
Not applicableNot Yet RecruitingNCT07453290
What this trial is testing

Dysregulation of the Soluble α-Klotho-FGF23 Axis in Hashimoto's Thyroiditis: A Case-Control Study

Who this might be right for
Autoimmune Thyroiditis
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital 150
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07221565
What this trial is testing

Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)

Who this might be right for
Systemic Lupus ErythematosusRheumatoid ArthritisMultiple Sclerosis+3 more
Truway Health, Inc. 120
Not applicableLooking for participantsNCT00059748
What this trial is testing

Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis

Who this might be right for
Autoinflammatory DiseaseJuvenile Dermatomyositis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 5,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT06897358
What this trial is testing

Leniolisib for Immune Dysregulation in CVID

Who this might be right for
Common Variable Immunodeficiency (CVID)
Pharming Technologies B.V. 20
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Very early researchLooking for participantsNCT02356653
What this trial is testing

Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC

Who this might be right for
LeukemiaInborn Errors of MetabolismBone Marrow Failure Syndromes+2 more
Children's Hospital of Philadelphia 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03663933
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation

Who this might be right for
Lymphoproliferative DisordersAutoimmune LymphoproliferativePrimary T-cell Immunodeficiency Disorders+2 more
National Cancer Institute (NCI) 71
Not applicableNot Yet RecruitingNCT07589062
What this trial is testing

Healthy Eating and Active Living for People Living With Multiple Sclerosis (HEAL MS): A Lifestyle Program for People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis
New York University Abu Dhabi 30
Testing effectiveness (Phase 2)Study completedNCT02277639
What this trial is testing

Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases

Who this might be right for
Bone Marrow Failure SyndromesImmunodeficienciesImmune Dysregulation Syndromes
Children's Hospital of Philadelphia 2
Not applicableLooking for participantsNCT05339529
What this trial is testing

Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)

Who this might be right for
Acute Aortic SyndromeAortic Dissection Type a
Nanjing Medical University 330
Load More Results